top of page

Drug Shortages AI

  • Apr 3, 2022
  • 1 min read

Updated: Aug 2

CheckMed, our newly formed company, is dedicated to leveraging artificial intelligence (AI) to predict shortages of vaccines, medical devices, and drugs. We firmly believe that AI holds the key to analysing data and making well-informed decisions. Prediction is only half the solution — see how ProPG supports bridging supply gaps during shortages.


Please see the CheckMed website for more details www.checkmed.ai CheckMed's predictive signals also feed directly into our new shortage planning tool for hospitals.


Drug Shortages AI
CheckMed




Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page